Some robots battling spread of coronavirus may not be needed

Numerous robots have been used by healthcare workers battling the ongoing Wuhan coronavirus outbreak—but is such a precaution always necessary?

The advanced technology was used in the United States to treat the country’s first diagnosed coronavirus patient, and a hotel in Hangzhou, China, is using a robot to deliver meals to more than 300 people who have been quarantined in a hotel. In other parts of China, robots are transporting drugs to and from different parts of the hospital—and some machines are even used to clean areas where it is believed coronavirus exposure took place.

According to Chloe Kent, a technology writer for GlobalData, these precautions seem unnecessary, especially when one remembers that the quarantined people haven’t displayed any symptoms of the deadly disease.

“Even if the coronavirus can be spread by people with no symptoms, who may be infected for two to 14 days before they start to feel sick, people who are sneezing and coughing are far more likely to spread the disease,” Kent said in a statement. “Quarantining people for weeks on end who may not be ill, and going so far as to have a robot deliver their meals, may be a recipe for social tension.”

Kent added that these medical robots “are flashy and advanced,” and “their contributions should be welcomed” if they can truly make a difference. “But doubling down on practices like handwashing, and reinforcing the importance of clear international communication” are much more important when it comes to keeping the disease from spreading.

Additional AI in Healthcare coverage of the Wuhan coronavirus outbreak can be read here and here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”